Marc Robillard is the founder of Tagworks Pharmaceuticals. Tagworks Pharmaceuticals has raised $65M in total funding. Latest round: Series A.
Marc Robillard is the founder and former CEO of Tagworks Pharmaceuticals, a biotech spin-out focused on 'click-to-release' cancer therapeutics. He led the company from its separation from Philips in 2011, overseeing its Series A financing until Ken Mills was appointed CEO in 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library